News
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
22h
A new study led by researchers at Yale University published in Environmental Health Perspectives, suggests that early-life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback